| Accession Number | 0001632901-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 11, 2026 |
| Document Date | Feb 10, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Medical Officer | Common Stock | โ | Feb 10, 2026 | Exercise/Conversion | 838 | $0.00 | $0.00 | 1,247 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Feb 10, 2026 | Tax Withholding | 417 | $492.84 | $205,514.28 | 830 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Feb 10, 2026 | Exercise/Conversion | 105 | $229.39 | $24,085.95 | 935 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Feb 10, 2026 | Sale | 105 | $494.65 | $51,938.25 | 830 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Feb 11, 2026 | Sale | 421 | $494.96 | $208,378.16 | 409 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Non-Qualified Stock Option (right to buy) | Derivative | Feb 10, 2026 | Exercise/Conversion | 105 | $0.00 | $0.00 | 1,257 | Direct | โ | View Details | |
EVP & Chief Medical Officer | Restricted Stock Units | Derivative | Feb 10, 2026 | Exercise/Conversion | 838 | $0.00 | $0.00 | 838 | Direct | โ | View Details |